Skip to main content

Security report for angelinipharma.hu

Angelini Pharma Magyarország Kft. · Healthcare · Hungary

Medium risk. 8 critical or high findings in GDPR outside view, Email security and 1 other check.

Security score

66/100

Risk levelMedium

0–100, higher is better. How it is calculated

Angelini Pharma Magyarország Kft. is a medium-sized pharmaceutical company operating in Hungary as part of the global Angelini S.p.a. group. The company focuses on brain health, oncology, pain management, and consumer health products, serving patients, healthcare professionals, and consumers. The website reflects a professional and consistent brand presence with clear navigation and relevant content in Hungarian. Technically, the site uses modern JavaScript libraries and privacy-focused analytics (Piwik PRO), with good mobile optimization and moderate performance. Security posture is solid with HTTPS and cookie consent mechanisms, though formal security policies and incident response contacts are not published. WHOIS data confirms legitimacy and consistency with the business claims. Overall, the website is trustworthy and well-maintained, supporting the company's market position in the healthcare sector.

Scanned

NIS2 and GDPR posture

GDPR outside view
10/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

Need hands-on remediation? Email guard@offseq.com

Keep watching angelinipharma.hu

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
82
Security headers
90
Email security
40
DNS health
75
Network security
100
GDPR outside view
10
Average
66

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Angelini Pharma operates as a pharmaceutical manufacturer and distributor with a strong European footprint, including Hungary. The business model centers on research-driven product development and consumer health solutions. The company leverages its parent company Angelini S.p.a. for global reach and resources. The website links to multiple country-specific Angelini Pharma domains, indicating a broad partnership ecosystem. Career opportunities and corporate information are transparently presented. The company holds certifications such as Top Employer Europe 2025, enhancing its credibility. The target audience includes patients, healthcare providers, and consumers seeking pharmaceutical and wellness products.

Security posture

The website demonstrates a mature security posture with enforced HTTPS and use of privacy-respecting analytics (Piwik PRO). Cookie consent is implemented, aligning with GDPR requirements. However, the absence of a published security policy and incident response contact details limits transparency. No security headers were detected in the HTML content, suggesting room for improvement. No vulnerable libraries or exposed sensitive data were found. Overall, the site is secure but could enhance trust by publishing formal security and incident response information.

Recommendations

  1. Publish a formal security policy page outlining security frameworks and practices.
  2. Provide clear incident response contact channels such as security@ or abuse@ emails.
  3. Implement and configure security headers like Content-Security-Policy and Strict-Transport-Security.
  4. Regularly audit and update third-party libraries to mitigate vulnerabilities.
  5. Enhance accessibility features to improve compliance and user experience.

Contact details published on the site

Addresses
Legal name
Angelini Pharma Magyarország Kft.
VAT number
HU13513980
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Angelini Pharma Magyarország Kft.
Description
Angelini Pharma is a pharmaceutical company committed to improving mental health, neurological disorders, and consumer health by investing in research and innovation. It operates globally with a focus on brain health, oncology, pain management, and consumer healthcare.
Key services
pharmaceutical products, research and development, consumer health products
Content quality
good
Branding
consistent

Technology

Stack
jQuery 3.7.1, jQuery Validation, Slick Carousel, Magnific Popup, Flip.js, Piwik PRO analytics
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Use of Piwik PRO for privacy-focused analytics
  • Cookie consent mechanism implemented

Analytics and tracking

Services
Piwik PRO
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Piwik PRO
Marketing tools
Piwik PRO analytics
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Content is professionally presented in Hungarian language.
  3. Strong presence of corporate and legal information in footer.
  4. Multiple social media channels linked to official company profiles.
  5. Use of modern JavaScript libraries and privacy-focused analytics.
  6. Cookie consent and privacy policies are implemented and accessible.
  7. No visible security policy or incident response information on site.
  8. WHOIS data supports legitimacy and consistency with business claims.
Technical notes

Notes

The website uses a modern JavaScript stack including jQuery 3.7.1, Slick Carousel, Magnific Popup, and Flip.js for UI components. Piwik PRO is used for analytics, emphasizing privacy compliance. Fonts are served from a dedicated Angelini domain, and static content is hosted on Google Cloud Storage. The site is mobile optimized with responsive design and includes basic accessibility features. Performance is moderate, with some opportunities for optimization. No CMS was explicitly detected, suggesting a custom or proprietary platform. Hosting details are limited but appear stable and secure. Overall, the technical infrastructure supports a professional and compliant digital presence.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with angelinipharma.hu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review angelinipharma.hu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.